148 related articles for article (PubMed ID: 37894903)
1. Computational Investigations on Reaction Mechanisms of the Covalent Inhibitors Ponatinib and Analogs Targeting the Extracellular Signal-Regulated Kinases.
Tian Y; Zhang M; Heng P; Hou H; Wang B
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894903
[TBL] [Abstract][Full Text] [Related]
2. Reversible versus irreversible inhibition modes of ERK2: a comparative analysis for ERK2 protein kinase in cancer therapy.
Khan S; Bjij I; Betz RM; Soliman ME
Future Med Chem; 2018 May; 10(9):1003-1015. PubMed ID: 29629569
[TBL] [Abstract][Full Text] [Related]
3. Computation of relative binding free energy for an inhibitor and its analogs binding with Erk kinase using thermodynamic integration MD simulation.
Wu KW; Chen PC; Wang J; Sun YC
J Comput Aided Mol Des; 2012 Oct; 26(10):1159-69. PubMed ID: 22986633
[TBL] [Abstract][Full Text] [Related]
4. Role of a cysteine residue in the active site of ERK and the MAPKK family.
Ohori M; Kinoshita T; Yoshimura S; Warizaya M; Nakajima H; Miyake H
Biochem Biophys Res Commun; 2007 Feb; 353(3):633-7. PubMed ID: 17194451
[TBL] [Abstract][Full Text] [Related]
5. Covalent vs. Non-Covalent Inhibition: Tackling Drug Resistance in EGFR - A Thorough Dynamic Perspective.
Akher FB; Farrokhzadeh A; Soliman MES
Chem Biodivers; 2019 Mar; 16(3):e1800518. PubMed ID: 30548188
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of covalent binding of ibrutinib to Bruton's tyrosine kinase revealed by QM/MM calculations.
Voice AT; Tresadern G; Twidale RM; van Vlijmen H; Mulholland AJ
Chem Sci; 2021 Jan; 12(15):5511-5516. PubMed ID: 33995994
[TBL] [Abstract][Full Text] [Related]
7. Covalent and non-covalent binding free energy calculations for peptidomimetic inhibitors of SARS-CoV-2 main protease.
Awoonor-Williams E; Abu-Saleh AAA
Phys Chem Chem Phys; 2021 Mar; 23(11):6746-6757. PubMed ID: 33711090
[TBL] [Abstract][Full Text] [Related]
8. Ponatinib is a pan-BCR-ABL kinase inhibitor: MD simulations and SIE study.
Tanneeru K; Guruprasad L
PLoS One; 2013; 8(11):e78556. PubMed ID: 24236021
[TBL] [Abstract][Full Text] [Related]
9. Using thermodynamic integration MD simulation to compute relative protein-ligand binding free energy of a GSK3β kinase inhibitor and its analogs.
Lee HC; Hsu WC; Liu AL; Hsu CJ; Sun YC
J Mol Graph Model; 2014 Jun; 51():37-49. PubMed ID: 24858254
[TBL] [Abstract][Full Text] [Related]
10. Acetylcholinesterase: mechanisms of covalent inhibition of wild-type and H447I mutant determined by computational analyses.
Cheng Y; Cheng X; Radić Z; McCammon JA
J Am Chem Soc; 2007 May; 129(20):6562-70. PubMed ID: 17461584
[TBL] [Abstract][Full Text] [Related]
11. Targeted Covalent Inhibition of Grb2-Sos1 Interaction through Proximity-Induced Conjugation in Breast Cancer Cells.
Yu Y; Nie Y; Feng Q; Qu J; Wang R; Bian L; Xia J
Mol Pharm; 2017 May; 14(5):1548-1557. PubMed ID: 28060514
[TBL] [Abstract][Full Text] [Related]
12. Atomistic understanding of the C·T mismatched DNA base pair tautomerization via the DPT: QM and QTAIM computational approaches.
Brovarets' OO; Hovorun DM
J Comput Chem; 2013 Nov; 34(30):2577-90. PubMed ID: 23955922
[TBL] [Abstract][Full Text] [Related]
13. Investigating the Impact of Covalent and Non-covalent Binding Modes of Inhibitors on Bruton's Tyrosine Kinase in the Treatment of B Cell Malignancies - Computational Insights.
Issahaku AR; Soliman MES
Curr Pharm Biotechnol; 2023; 24(6):814-824. PubMed ID: 35718983
[TBL] [Abstract][Full Text] [Related]
14. Computational design, chemical synthesis, and biological evaluation of a novel ERK inhibitor (BL-EI001) with apoptosis-inducing mechanisms in breast cancer.
Liu B; Fu L; Zhang C; Zhang L; Zhang Y; Ouyang L; He G; Huang J
Oncotarget; 2015 Mar; 6(9):6762-75. PubMed ID: 25742792
[TBL] [Abstract][Full Text] [Related]
15. o-Quinone methide as alkylating agent of nitrogen, oxygen, and sulfur nucleophiles. The role of H-bonding and solvent effects on the reactivity through a DFT computational study.
Di Valentin C; Freccero M; Zanaletti R; Sarzi-Amadè M
J Am Chem Soc; 2001 Aug; 123(34):8366-77. PubMed ID: 11516286
[TBL] [Abstract][Full Text] [Related]
16. Absolute and relative binding free energy calculations of the interaction of biotin and its analogs with streptavidin using molecular dynamics/free energy perturbation approaches.
Miyamoto S; Kollman PA
Proteins; 1993 Jul; 16(3):226-45. PubMed ID: 8346190
[TBL] [Abstract][Full Text] [Related]
17. The influence of hydrogen bonding interactions on the C-H bond activation step in class I ribonucleotide reductases.
Zipse H
Org Biomol Chem; 2003 Feb; 1(4):692-9. PubMed ID: 12929456
[TBL] [Abstract][Full Text] [Related]
18. Linear Discriminant Analysis for the in Silico Discovery of Mechanism-Based Reversible Covalent Inhibitors of a Serine Protease: Application of Hydration Thermodynamics Analysis and Semi-empirical Molecular Orbital Calculation.
Masuda Y; Yoshida T; Yamaotsu N; Hirono S
Chem Pharm Bull (Tokyo); 2018; 66(4):399-409. PubMed ID: 29607905
[TBL] [Abstract][Full Text] [Related]
19. Fundamental reaction pathway and free energy profile of proteasome inhibition by syringolin A (SylA).
Wei D; Tang M; Zhan CG
Org Biomol Chem; 2015 Jun; 13(24):6857-65. PubMed ID: 26018983
[TBL] [Abstract][Full Text] [Related]
20. Atomistic-Level Description of the Covalent Inhibition of SARS-CoV-2 Papain-like Protease.
Hognon C; Marazzi M; García-Iriepa C
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]